Diabetes and arterial hypertension

Italian Heart Journal Supplement

Volumn 2, Issue 11, 2001, Pages 1170-1180

  Dal Palu C ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

ACE inhibitors; Antihypertensive drugs; Diabetes; Hypertension; Obesity; Syndrome X

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROTON; SODIUM ION;

ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; DEVELOPED COUNTRY; EPIDEMIC; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; MEDICAL RESEARCH; METABOLIC DISORDER; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROGNOSIS; PROTEINURIA; PROTON SODIUM EXCHANGE; SYNDROME X; THROMBOPHILIA; ARTERIOSCLEROSIS; DIABETES MELLITUS; INSULIN RESISTANCE; REVIEW;

ARTERIOSCLEROSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERTENSION; INSULIN RESISTANCE; OBESITY;

EID: 0035676343     PISSN: 11294728     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria
2. Diabete, ipertensione e rischio cardiovascolare
3. Iperglicemia post-prandiale e complicazioni cardiovascolari
4. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure
5. Prevalence of arterial hypertension in diabetic patients before and after the JNC-V
6. Cardiovascular disease and its risk factors in IDDM in Europe
7. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality
8. Obesity, insulin resistance and diabetes, a worldwide epidemic
9. Ipertensione e diabete
10. I fattori metabolici
11. Predisposition to essential hypertension and the development of diabetic nephropathy
12. Insulin resistance and cardiovascular disease
13. Relationship between insulin and carotid atherosclerosis in the general population
14. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease
15. Hypertension and associated metabolic abnormalities. The role of insulin resistance and the sympathoadrenal system
16. Slow glucose-removal rate and hyperinsulinemia precede the development of type II diabetes in offspring of diabetic parents
17. Hyperinsulinemia, circadian variation of blood pressure and end-organ damage in hypertension
18. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type II diabetes (UKPDS 33)
19. Documento di Consenso. Compenso glicemico e malattia cardiovascolare nel diabete mellito di tipo 2: Oltre la glicemia a digiuno e l'emoglobina glicata
20. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: A systemic overview of the literature
21. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type II diabetes (UKPDS 34)
22. La lezione dell'UKPDS
23. A due anni di distanza dai risultati dello studio UKPDS: Quesiti e risposte
24. Management of patients with hypertension and diabetes mellitus: Advances in the evidence for intensive treatment
25. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38
26. High blood pressure and diabetes mellitus. Are all antihypertensive drug created equal?
27. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension
28. Effect of calcium-channel blockade in older patients with diabetes and systolic hypertension
29. Chinese trial on isolated systolic hypertension in the elderly
30. Blood pressure, stroke and coronary heart disease. Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
31. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
32. Benefits and potential harm of lowering high blood pressure
33. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 39)
34. Outcome results of the Fosinopril versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM
35. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
36. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial
37. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
38. Clinical study of the month. The STOP-2 study of arterial hypertension in the elderly
39. Preserving renal function in adults with hypertension and diabetes: A consensus approach
40. Hypertension and diabetes. New therapeutic options